ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AMA Names Dr. John Whyte Next CEO/EVP

CHICAGO, May 09, 2025 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) named John J. Whyte, M.D., M.P.H., as its next chief executive officer and executive vice president. Dr. Whyte will assume operational leadership of the nation’s largest physician’s group on July 1, 2025.

Dr. Whyte comes to the AMA with a background in clinical medicine, government, and the private sector. A practicing physician for 27 years, he has deep experience in federal, state and local health policy paired with a proven record of strategic management and innovation in the private sector.

He served in leadership positions at the Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services, U.S. Food and Drug Administration as well as the media company Discovery Communications. Most recently, he was the chief medical officer at WebMD, the health news and information company based in New York.

“Dr. Whyte is an exceptionally qualified leader who has distinguished himself across many fronts. He is uniquely positioned to lead the AMA at this pivotal time and offers a deep and nuanced understanding of the AMA’s mission, governance, and evolving role—ensuring both continuity and meaningful progress toward the association’s goals,” said AMA Board Chair, Michael Suk, M.D., J.D., M.P.H., M.B.A.

On his appointment, Dr. Whyte said, “I am honored to join the AMA as CEO and serve all patients and physicians across the country. I have tremendous respect and admiration for this venerable, science-based organization and its important work that improves the lives of millions of people. I see significant opportunities for a strong and vibrant AMA to fulfill its core mission to promote the art and science of medicine and the betterment of public health.”

A board-certified internist, Dr. Whyte completed his medical degree at Hahnemann University School of Medicine, conducted his residency training at Duke University Medical Center, and earned his Master of Public Health degree in health policy and management at Harvard University.

Dr. Whyte has written extensively for both professional and consumer audiences, including five best-selling books. A recognized leader during the COVID-19 pandemic, he was named one of the Top 20 Health Influencers for his public health leadership.

Dr. Whyte will succeed James L. Madara, M.D., who announced last June plans to end his 14-year tenure as AMA CEO at the conclusion of his current contract.


AMA Media & Editorial
American Medical Association 
312-464-4430
media@ama-assn.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  211.74
+4.07 (1.96%)
AAPL  252.82
+2.70 (1.08%)
AMD  196.58
+3.19 (1.65%)
BAC  47.06
+0.34 (0.73%)
GOOG  304.42
+2.96 (0.98%)
META  627.45
+13.74 (2.24%)
MSFT  399.95
+4.40 (1.11%)
NVDA  183.22
+2.97 (1.65%)
ORCL  155.97
+0.86 (0.55%)
TSLA  395.56
+4.36 (1.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.